Autolus is a biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Business Model:
Revenue: $4.4M
Employees: 201-500
Address: 191 Wood Lane
City: London
State: england
Zip: W12 7FP
Country: GB
Autolus is a biopharmaceutical company that develops and commercializes T-cell immunotherapies for the treatment of cancer.
Contact Phone:
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
6/22/2018
Ticker Symbol:
AUTL
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|